Immuno-based retargeted endopeptidase activity assays | Patent Number 10900967

US 10900967 B2
Application Number16504870
Publication NumberUS 20190324041 A1
Pendency1 year, 6 months, 23 days
Filled DateJul 8, 2019
Priority DateMar 13, 2009
Publication DateOct 24, 2019
Expiration DateMar 12, 2029
Inventor/ApplicantsDianne D. Hodges
Hong Zhu
Ester Fernandez-Salas
Joanne Wang
ExaminesCARLSON, KAREN C
Art Unit1656
Technology Center1600
Assignments
Allergan
Current
AllerganAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.